PHIO insider filings

Phio Pharmaceuticals Corp. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-16. Screen PHIO transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 13 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Plott Ronald Todd — Director33 legs · 28,300 sh · $25,539—1
Bitterman Robert J — Chairman, Pres. & CEO, Director42 legs · 27,000 sh · $22,558—2
Deming David H — Director24 legs · 24,000 sh · $19,889——
BRADFORD PATRICIA A — Director22 legs · 18,500 sh · $18,943——
Carson Lisa Cabott — Chief Financial Officer2——2

Recent insider filings — Phio Pharmaceuticals Corp.

FiledFormInsiderReported transactionsSource
2026-11-164Deming David H — DirectorPurchase (P): 9,000 @ $0.81 · Purchase (P): 3,000 @ $0.83EDGAR
2026-11-124Deming David H — DirectorPurchase (P): 6,800 @ $0.84 · Purchase (P): 5,200 @ $0.84EDGAR
2026-11-104Plott Ronald Todd — DirectorPurchase (P): 18,300 @ $0.83EDGAR
2026-11-104Bitterman Robert J — Chairman, Pres. & CEO, DirectorPurchase (P): 25,000 @ $0.82EDGAR
2026-09-304Plott Ronald Todd — DirectorPurchase (P): 5,000 @ $1.03 · Purchase (P): 5,000 @ $1.04EDGAR
2026-09-294Plott Ronald Todd — DirectorGrant/award (A): 17,000 @ $0EDGAR
2026-09-294Bitterman Robert J — Chairman, Pres. & CEO, DirectorGrant/award (A): 400,000 @ $0EDGAR
2026-09-294Carson Lisa Cabott — Chief Financial OfficerGrant/award (A): 108,000 @ $0EDGAR
2026-09-254BRADFORD PATRICIA A — DirectorPurchase (P): 6,500 @ $1.01EDGAR
2026-09-234Bitterman Robert J — Chairman, Pres. & CEO, DirectorPurchase (P): 2,000 @ $1.03EDGAR
2026-09-164BRADFORD PATRICIA A — DirectorPurchase (P): 12,000 @ $1.03EDGAR
2026-09-154Bitterman Robert J — Chairman, Pres. & CEO, DirectorTax withholding (F): 68,550 @ $1.03EDGAR
2026-09-154Carson Lisa Cabott — Chief Financial OfficerTax withholding (F): 12,888 @ $1.03EDGAR
2026-08-204Plott Ronald Todd — DirectorPurchase (P): 15,000 @ $1.14EDGAR
2026-08-194Bitterman Robert J — Chairman, Pres. & CEO, DirectorPurchase (P): 10,000 @ $1.06EDGAR
2026-06-294Bitterman Robert J — Chairman, Pres. & CEO, DirectorPurchase (P): 10,000 @ $0.99EDGAR
2026-02-064Freeman Jonathan E — DirectorGrant/award (A): 16,600 @ $0EDGAR
2026-02-064Deming David H — DirectorGrant/award (A): 23,800 @ $0EDGAR
2026-02-064Carson Lisa Cabott — Chief Financial OfficerGrant/award (A): 47,000 @ $0EDGAR
2026-02-064Lockshin Curtis — DirectorGrant/award (A): 16,600 @ $0EDGAR
2026-02-064BRADFORD PATRICIA A — DirectorGrant/award (A): 18,500 @ $0EDGAR
2026-02-064Bitterman Robert J — Chairman, Pres. & CEO, DirectorGrant/award (A): 120,000 @ $0EDGAR
2026-01-024Bitterman Robert J — Chairman, Pres. & CEO, DirectorPurchase (P): 5,000 @ $1.03EDGAR
2025-12-294Bitterman Robert J — Chairman, Pres. & CEO, DirectorPurchase (P): 5,000 @ $1.02EDGAR
2025-11-244Bitterman Robert J — Chairman, Pres. & CEO, DirectorPurchase (P): 5,000 @ $1.14EDGAR
2025-11-194Bitterman Robert J — Chairman, Pres. & CEO, DirectorPurchase (P): 5,000 @ $1.27EDGAR
2025-09-154Deming David H — DirectorGrant/award (A): 14,000 @ $0EDGAR
2025-09-154Freeman Jonathan E — DirectorGrant/award (A): 14,700 @ $0EDGAR
2025-09-154Ferrara Robert L — DirectorGrant/award (A): 23,000 @ $0EDGAR
2025-09-154Carson Lisa Cabott — VP, Finance and AdministrationGrant/award (A): 47,000 @ $0EDGAR
2025-09-154/AFerrara Robert L — DirectorGrant/award (A): 23,100 @ $0EDGAR
2025-09-154Lockshin Curtis — DirectorGrant/award (A): 16,200 @ $0EDGAR
2025-09-154BRADFORD PATRICIA A — DirectorGrant/award (A): 18,800 @ $0EDGAR
2025-09-154Bitterman Robert J — Chairman, Pres. & CEO, DirectorTax withholding (F): 4,111 @ $2.32 · Grant/award (A): 250,000 @ $0EDGAR
2025-06-114Ferrara Robert L — DirectorPurchase (P): 2,500 @ $2.42EDGAR
2025-06-114Bitterman Robert J — Chairman, Pres & CEO, DirectorPurchase (P): 2,000 @ $2.42EDGAR
2025-06-104Bitterman Robert J — Chairman, Pres & CEO, DirectorPurchase (P): 1,500 @ $2.75EDGAR
2025-05-234Bitterman Robert J — Chairman, Pres & CEO, DirectorPurchase (P): 3,000 @ $1.77 · Purchase (P): 1,200 @ $1.78EDGAR
2025-05-214Ferrara Robert L — DirectorPurchase (P): 2,500 @ $1.82EDGAR
2024-09-134Infarinato Robert M. — VP, CFOGrant/award (A): 3,000 @ $0EDGAR
2024-09-134Freeman Jonathan E — DirectorGrant/award (A): 1,000 @ $0EDGAR
2024-09-134Bitterman Robert J — Chairman, Pres & CEO, DirectorGrant/award (A): 15,500 @ $0EDGAR
2024-09-124Ferrara Robert L — DirectorGrant/award (A): 10,000 @ $0EDGAR
2024-09-124Lockshin Curtis — DirectorGrant/award (A): 2,000 @ $0EDGAR
2024-09-124BRADFORD PATRICIA A — DirectorGrant/award (A): 8,000 @ $0EDGAR
2024-08-154Infarinato Robert M. — VP, Chief Financial OfficerGrant/award (A): 8,000 @ $0EDGAR
2024-06-114Bitterman Robert J — President & CEO, DirectorPurchase (P): 1,000 @ $0.74EDGAR
2024-06-104Bitterman Robert J — President & CEO, DirectorPurchase (P): 1,000 @ $0.75EDGAR
2024-03-054Kontulis Caitlin — Secretary & VP Finance & AdminTax withholding (F): 335 @ $0.96EDGAR
2024-02-274Bitterman Robert J — President & CEO, DirectorPurchase (P): 2,500 @ $0.91EDGAR

Recent 8-K events — Phio Pharmaceuticals Corp.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-208-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-138-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-288-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-148-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-218-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-088-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-308-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=PHIO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs